Original Report

Illness perceptions matter: understanding quality of life and advanced illness behaviors in female patients with late-stage cancer


 

Background Patients with late-stage cancer are living longer, making it important to understand factors that contribute to maintaining quality of life (QOL) and completing advanced illness behaviors (eg, advance directives).

Objective To examine whether illness perceptions—the cognitive beliefs that patients form about their cancer—may be more important guides to adjustment than clinical characteristics of the cancer.

Methods In a cross-sectional study, 105 female patients diagnosed with stage III (n 66) or IV (n 39) breast (n 44), gynecological (n 38), or lung (n 23) cancer completed self-report measures of illness perceptions, QOL, and advanced illness behaviors. Clinical data was obtained from medical records.

Results Despite modest associations, patients’ beliefs about the cancer were clearly unique from the clinical characteristics of the cancer. Illness perception variables accounted for a large portion of the variance (PS .01) for QOL and advanced illness behaviors, whereas clinical characteristics did not. QOL scores were predicted by patients’ reports of experiencing more cancer related symptoms (ie, illness identity), believing that their cancer is central to their self-identity, and higher income. Higher completion of advanced illness behaviors was predicted by higher income, the cancer being recurrent, and participants perceiving their cancer as more severe but also more understandable.

Limitations This study was limited by a cross-sectional design, small sample size, and focus on female patients.

Conclusion Addressing patients’ beliefs about their cancer diagnosis may provide important targets for intervention to improve QOL and illness behaviors in patients with late-stage cancer.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

The demands of cancer survivorship: the who, what, when, where, why, and how
MDedge Hematology and Oncology
Many women with cancer not told about impaired fertility risk
MDedge Hematology and Oncology
Family history, genetic testing, and the electronic health record
MDedge Hematology and Oncology
Low-grade toxicities take a toll on older cancer patients
MDedge Hematology and Oncology
Sulfasalazine may make radiation-induced diarrhea worse
MDedge Hematology and Oncology
Self-administration of romiplostim in patients with chronic immune thrombocytopenia
MDedge Hematology and Oncology
Extended-release hydrocodone approved by FDA
MDedge Hematology and Oncology
Five criteria doubled palliative care, cut hospital readmissions
MDedge Hematology and Oncology
Inspiratory muscle training improved subjective breathlessness in lung cancer
MDedge Hematology and Oncology
Use of the JAK1/JAK2 inhibitor ruxolitinib in the treatment of patients with myelofibrosis
MDedge Hematology and Oncology